The muscle relaxant that was originally designed to stop seizures

The muscle relaxant that was originally designed to stop seizures
Image: Intellect (generated)

In short: In 1962, Swiss chemist Heinrich Keberle synthesized a compound intended to treat epilepsy. While it failed as an anti-epileptic, it revealed a potent ability to calm the central nervous system. Today, this derivative of GABA is a cornerstone in treating chronic muscle spasticity and is being explored for addiction.

Baclofen, sold under brands like Lioresal, functions as a potent GABAB receptor agonist. By acting as an inhibitory ligand, it is thought to block mono- and polysynaptic reflexes by inhibiting the release of excitatory neurotransmitters. This mechanism makes it a primary treatment for spasticity resulting from multiple sclerosis or spinal cord injuries. Because it is rapidly absorbed and has a serum half-life of roughly 2 to 4 hours, patients often require frequent dosing to maintain control.

The drug's delivery methods have evolved significantly. While oral administration is standard, severe cases that are refractive to maximum oral doses may require intrathecal delivery. This involves an implanted, computer-controlled pump that delivers medication directly into the spinal canal. This method achieves cerebrospinal fluid concentrations more than 10 times higher than oral routes while keeping blood levels almost undetectable, thereby minimizing systemic side effects.

Beyond muscle disorders, baclofen is a subject of intense study regarding alcohol use disorder. It is thought to work by decreasing dopamine release in the mesolimbic pathway associated with alcohol. While some agencies, such as France's ANSM, have issued recommendations for its use in alcoholism, clinical trials—including a high-dose study at the University of Amsterdam—have not yet found conclusive evidence of its effectiveness for all patients. However, it remains a significant tool for reducing relapse risk and increasing abstinence days in many contexts.

Safety is a critical nuance for clinicians. Abruptly stopping baclofen can trigger a severe withdrawal syndrome characterized by hallucinations, seizures, and even extreme muscle rigidity. Furthermore, combining the drug with other sedatives like alcohol or benzodiazepines can dangerously increase sedative effects or, in high doses, cause seizures.

Opens the Intellect+ feed with this card first. Swipe up for the next one.

Sources

  • Summary by Intellect · source: Baclofen

To cite this card, link to https://intellectplus.co.uk/app/technology-baclofen.

How we source, check and correct cards: Editorial standards.

General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.

Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?

Related

Finding something worth knowing…